Stock screenerAll disclosures →
EDGAR →
VTRS
Conviction 55HealthcareScan · Tue, Sep 8, 2026VTRS$16.62-1.54%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 6.88M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price16.62
Change-1.54%
Gap-1.45%
Rel volume0.53×
Avg volume8.2M
Avg $ vol134.75M
SMA 2016.49
SMA 5016.77
SMA 20014.75
Price vs 50-0.89%
Price vs 200+12.67%
MA stackmixed
50/200 cross—
Supertrenddown · 17.51
RSI (14)49
MACD hist0.05
MACD crossbull · 8d
Stoch %K / %D49 / 64
ADX (14)14
+DI / −DI22 / 21
RSI divergence—
MACD divergence—
ATR %+2.73%
ADR %2.35%
52w high17.86
52w low9.49
From 52w high-6.94%
Above 52w low+75.13%
New 52w highNo
SqueezeOff
Bollinger width7.64%
%B0.61
Donchian pos52.86%
Donchian high17.28
Donchian low15.88
AVWAP (52w high)16.50
vs AVWAP high+0.74%
AVWAP (52w low)14.27
vs AVWAP low+16.50%
OBV trendFlat
Chaikin MF (20)-0.04
Today vs 20d0.53×
Avg vol (14d)6.88M
Avg vol (20d)8.2M
Avg $ vol (20d)134.75M
Market cap19.09B
RS 3m (vs SPY)+1.87%
RS 6m (vs SPY)+4.66%
RS line new highNo
Trend template7/8
Technical rank67.0
1 week+0.67%
1 month+1.16%
3 months+4.33%
6 months+16.88%
1 year+58.29%
YTD+33.39%
P/E—
P/B-94.97
P/S1.34
P/FCF9.85
EPS-3.00
Div yield—
ROE0.00%
ROA0.00%
Debt/Eq-66.42
Current1.58
EV/EBITDA233.39
Gross margin35.18%
Net margin0.00%
Rev growth-3.01%
EPS growth—
Price target19.50
Target upside17.33%
Analyst ratingBuy
Institutional104.34%
Ent. value31.55B
Revenue3.75B
Net income-169M
Gross profit1.46B
Free cash flow1.94B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out1.16B
Employees30K
ListedFri, Feb 23, 1973
Free float1.16B
Float %99.7%
Short interest37.02M
Days to cover3.0d
Short volume64.8%
Squeeze score38 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.69 vs $0.62
Last surprise+11.3% beat
Setup gradeC
Conviction55 / 100
Pattern quality—
Tech rank67.0 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance18.23
Support15.93
Days since event—
Candle confirm—
News sentiment—
Financials as of Sun, Sep 27, 2020 · quarterly.
Congress activity
Disclosed STOCK Act trades in VTRS · 3 recent
Insider activity
SEC Form 4 transactions in VTRS · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Enrietti Andrew See Remarks · Common Stock · 2026-08-15 | Exercise | 25.13K | — | 2026-08-15 | 2026-08-18 |
Enrietti Andrew See Remarks · Common Stock · 2026-08-15 | Tax | 10.93K | $177K | 2026-08-15 | 2026-08-18 |
Enrietti Andrew See Remarks · Common Stock · 2026-08-15 | Exercise | 999 | — | 2026-08-15 | 2026-08-18 |
Enrietti Andrew See Remarks · Common Stock · 2026-08-15 | Tax | 435 | $7K | 2026-08-15 | 2026-08-18 |
Enrietti Andrew See Remarks · Restricted Stock Units · 2026-08-15 | Exercise | 25.13K | — | 2026-08-15 | 2026-08-18 |
Enrietti Andrew See Remarks · Dividend Equivalent Units · 2026-08-15 | Exercise | 998.364 | — | 2026-08-15 | 2026-08-18 |
Campbell Paul See Remarks · Common Stock · 2026-06-25 | Sell | 50.08K | $810K | 2026-06-25 | 2026-06-26 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Tax | 17.45K | $242K | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Exercise | 39.34K | $0 | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Exercise | 3.64K | $0 | 2026-04-15 | 2026-04-16 |
SEC filings
EDGAR filings in VTRS · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.